tiprankstipranks
Trending News
More News >
Privia Health Group (PRVA)
NASDAQ:PRVA
US Market

Privia Health Group (PRVA) Ratios

Compare
213 Followers

Privia Health Group Ratios

PRVA's free cash flow for Q4 2025 was $0.09. For the 2025 fiscal year, PRVA's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.60 1.60 1.86 1.81 2.09
Quick Ratio
1.60 1.60 1.86 1.81 2.09
Cash Ratio
0.84 0.84 1.09 1.01 1.32
Solvency Ratio
<0.01 <0.01 0.05 0.08 -0.01
Operating Cash Flow Ratio
<0.01 <0.01 0.24 0.21 0.18
Short-Term Operating Cash Flow Coverage
0.07 0.07 0.00 0.00 0.00
Net Current Asset Value
$ 332.57B$ 332.57B$ 382.49M$ 308.29M$ 278.20M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
0.01 0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
1.86 1.86 1.79 1.78 1.59
Debt Service Coverage Ratio
0.02 0.02 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
3.31 3.29 0.00 0.00 0.00
Interest Debt Per Share
77.37 78.01 0.05 0.07 0.10
Net Debt to EBITDA
-9.23K -8.73K -20.02 -14.02 23.12
Profitability Margins
Gross Profit Margin
9.49%9.40%10.19%9.74%9.93%
EBIT Margin
1.93%2.07%0.98%1.25%-1.41%
EBITDA Margin
2.40%2.54%1.40%1.64%-1.07%
Operating Profit Margin
1.61%1.61%0.98%1.25%-1.41%
Pretax Profit Margin
2.07%2.07%1.61%1.75%-1.37%
Net Profit Margin
1.08%1.08%0.83%1.39%-0.63%
Continuous Operations Profit Margin
1.40%1.40%0.98%1.27%-0.89%
Net Income Per EBT
52.16%52.16%51.61%79.53%46.21%
EBT Per EBIT
128.34%128.34%164.11%140.54%97.17%
Return on Assets (ROA)
<0.01%<0.01%1.27%2.31%-1.08%
Return on Equity (ROE)
0.01%<0.01%2.26%4.11%-1.72%
Return on Capital Employed (ROCE)
<0.01%<0.01%2.47%3.37%-3.62%
Return on Invested Capital (ROIC)
<0.01%<0.01%1.51%2.43%-2.34%
Return on Tangible Assets
<0.01%<0.01%1.63%3.06%-1.41%
Earnings Yield
0.80%0.79%0.62%0.86%-0.34%
Efficiency Ratios
Receivables Turnover
<0.01 <0.01 5.49 5.70 7.16
Payables Turnover
4.02 4.03 159.87 189.83 181.53
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.23 0.23 286.06 185.49 118.23
Asset Turnover
<0.01 <0.01 1.53 1.66 1.71
Working Capital Turnover Ratio
0.01 0.01 4.96 5.51 4.99
Cash Conversion Cycle
68.84K 68.84K 64.18 62.10 49.00
Days of Sales Outstanding
68.93K 68.93K 66.46 64.02 51.01
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
90.71 90.62 2.28 1.92 2.01
Operating Cycle
68.93K 68.93K 66.46 64.02 51.01
Cash Flow Ratios
Operating Cash Flow Per Share
1.33 1.34 0.92 0.69 0.43
Free Cash Flow Per Share
1.32 1.33 0.87 0.69 0.43
CapEx Per Share
<0.01 <0.01 0.04 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 0.95 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
136.17 136.17 21.76 714.91 453.81
Capital Expenditure Coverage Ratio
136.17 136.17 21.76 714.91 453.81
Operating Cash Flow Coverage Ratio
0.02 0.02 19.55 9.75 4.10
Operating Cash Flow to Sales Ratio
0.08 0.08 0.06 0.05 0.03
Free Cash Flow Yield
5.64%5.60%4.47%3.00%1.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
125.07 126.39 162.27 116.48 -292.82
Price-to-Sales (P/S) Ratio
1.36 1.36 1.34 1.62 1.85
Price-to-Book (P/B) Ratio
<0.01 <0.01 3.68 4.79 5.04
Price-to-Free Cash Flow (P/FCF) Ratio
17.74 17.86 22.39 33.32 53.38
Price-to-Operating Cash Flow Ratio
17.54 17.73 21.36 33.28 53.26
Price-to-Earnings Growth (PEG) Ratio
4.38 2.17 -4.06 -0.41 3.12
Price-to-Fair Value
<0.01 <0.01 3.68 4.79 5.04
Enterprise Value Multiple
-9.18K -8.68K 76.24 84.88 -149.64
Enterprise Value
-467.28B -467.26B 1.85B 2.31B 2.18B
EV to EBITDA
-9.18K -8.68K 76.24 84.88 -149.64
EV to Sales
-220.12 -220.11 1.06 1.39 1.60
EV to Free Cash Flow
-2.88K -2.88K 17.73 28.60 46.24
EV to Operating Cash Flow
-2.86K -2.86K 16.92 28.56 46.14
Tangible Book Value Per Share
2.96K 2.99K 3.62 3.09 3.02
Shareholders’ Equity Per Share
5.98K 6.03K 5.32 4.81 4.51
Tax and Other Ratios
Effective Tax Rate
0.32 0.32 0.39 0.28 0.35
Revenue Per Share
17.23 17.38 14.54 14.20 12.26
Net Income Per Share
0.19 0.19 0.12 0.20 -0.08
Tax Burden
0.52 0.52 0.52 0.80 0.46
Interest Burden
1.07 1.00 1.64 1.41 0.97
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
13.84 65.08 0.07 0.07 0.10
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.00 0.05
Income Quality
6.95 7.13 7.60 3.50 -3.91
Currency in USD